top of page
Cost-effectiveness of ferritin screening thresholds for iron deficiency in reproductive-age women
Wang D, Sra M, Glaeser-Khan S, Wang DY, Moshashaian-Asl R, Ito S, Cuker A, Goshua G
American Journal of Hematology
April
2025
ABO blood group and COVID-19 severity: associations with endothelial and adipocyte activation in critically ill patients
Stukas S, Goshua G, Conway EM, Lee AYY, Hoiland RL, Sekhon MS, Y C Chen L.
PLoS One
April
2025
Using distributional cost-effectiveness analysis
Goshua G, Varghese M, Ito S, Pandya A
JACC
April
2025
Integrating epidemiology and genomics data to estimate the prevalence of acquired cysteine drug targets in the US cancer patient population
Arun AS, Liarakos S, Mendiratta G, Kim J, Goshua G, Olson P, Stites EC
Pharmacogenomics Journal
March
2025
Cost-effectiveness of enasidenib versus conventional care for older patients with IDH2- mutant refractory/relapsed AML
Alhajahjeh A, Patel KK, Shallis RM, Podoltsev NA, Kewan T, Stempel JM, Mendez, L, Huntington SF, Stahl M, Goshua G, Bewersdorf JP, Zeidan AM
Leukemia & Lymphoma
March
2025
Cost-effectiveness of iptacopan for paroxysmal nocturnal hemoglobinuria
Ito S*, Chetlapalli K*, Wang D, Potnis KC, Richmond R, Krumholz HM, Lee AI, Cuker A, Goshua G
Blood
January
2025
Cost-effectiveness of sutimlimab in cold agglutinin disease
Ito S, Wang D, Purcell A, Chetlapalli K, Lee AI, Cuker A, Goshua G
American Journal of Hematology
August
2024
Cancer research is not correlated with driver gene mutation burdens
Mendiratta G, Liarakos D, Tong M, Ito S, Ke E, Goshua G, Stites EC
Med
July
2024

Featured Publications (5)

All Selected Publications

Cost-effectiveness of ferritin screening thresholds for iron deficiency in reproductive-age women
Wang D, Sra M, Glaeser-Khan S, Wang DY, Moshashaian-Asl R, Ito S, Cuker A, Goshua G
American Journal of Hematology
2025
April
RECOGNITIONS:

PRACTICAL IMPACT:
ABO blood group and COVID-19 severity: associations with endothelial and adipocyte activation in critically ill patients
Stukas S, Goshua G, Conway EM, Lee AYY, Hoiland RL, Sekhon MS, Y C Chen L.
PLoS One
2025
April
RECOGNITIONS:

PRACTICAL IMPACT:
Using distributional cost-effectiveness analysis
Goshua G, Varghese M, Ito S, Pandya A
JACC
2025
April
RECOGNITIONS:

PRACTICAL IMPACT:
Integrating epidemiology and genomics data to estimate the prevalence of acquired cysteine drug targets in the US cancer patient population
Arun AS, Liarakos S, Mendiratta G, Kim J, Goshua G, Olson P, Stites EC
Pharmacogenomics Journal
2025
March
RECOGNITIONS:

PRACTICAL IMPACT:
Cost-effectiveness of enasidenib versus conventional care for older patients with IDH2- mutant refractory/relapsed AML
Alhajahjeh A, Patel KK, Shallis RM, Podoltsev NA, Kewan T, Stempel JM, Mendez, L, Huntington SF, Stahl M, Goshua G, Bewersdorf JP, Zeidan AM
Leukemia & Lymphoma
2025
March
RECOGNITIONS:

PRACTICAL IMPACT:
Cost-effectiveness of iptacopan for paroxysmal nocturnal hemoglobinuria
Ito S*, Chetlapalli K*, Wang D, Potnis KC, Richmond R, Krumholz HM, Lee AI, Cuker A, Goshua G
Blood
2025
January
RECOGNITIONS:

PRACTICAL IMPACT:
Cost-effectiveness of sutimlimab in cold agglutinin disease
Ito S, Wang D, Purcell A, Chetlapalli K, Lee AI, Cuker A, Goshua G
American Journal of Hematology
2024
August
RECOGNITIONS:

PRACTICAL IMPACT:
Cancer research is not correlated with driver gene mutation burdens
Mendiratta G, Liarakos D, Tong M, Ito S, Ke E, Goshua G, Stites EC
Med
2024
July
RECOGNITIONS:

PRACTICAL IMPACT:

Prophylactic weekly efanesoctocog alfa versus standard-care factor VIII in people living with severe hemophilia A: a cost-effectiveness analysis

Ito S, Potnis KC, Harvey JP, Sra M, Bewersdorf JP, Bona RD, Krumholz HM, Cuker A, Pandya A, Goshua G.
Annals of Internal Medicine
2025
June
FEATURED
RECOGNITIONS:

Gap: First conventional and distributional cost-effectiveness analysis in the care of people living with hemophilia A (Yale-HSPH-Mayo-Penn collaboration). ASH Abstract Achievement Award (S. Ito).

PRACTICAL IMPACT:

Cost-effectiveness of Lynch syndrome screening in colorectal cancer: universal germline vs sequential screening

Ito S, Xicola RM, Sra M, Potnis KC, Singh V, Gershkovich P, Stites E, Gibson J, Krumholz HM, Llor X, Goshua G
Clinical Gastroenterology & Hepatology
2025
April
FEATURED
RECOGNITIONS:

Gap: Real-world diagnostic attrition leads to missed diagnoses of inherited Lynch syndrome in probands with colorectal cancer (CRC) and their relatives. Health economic rationale for upfront germline tumor testing in probands to improve population health.

PRACTICAL IMPACT:

Cost-effectiveness of ferritin screening thresholds for iron deficiency in reproductive-age women

Wang D, Sra M, Glaeser-Khan S, Wang DY, Moshashaian-Asl R, Ito S, Cuker A, Goshua G
American Journal of Hematology
2025
April
FEATURED
RECOGNITIONS:

Gap: First cost-effectiveness analysis of ferritin screening thresholds in the care of people living with iron deficiency (Yale-Mayo-Vermont-Penn collaboration). 2024 ASH Press Program Selection, 2025 Highlights of ASH, ASH Abstract Achievement Award (D. Wang).

PRACTICAL IMPACT:

Cost-effectiveness of iptacopan for paroxysmal nocturnal hemoglobinuria

Ito S*, Chetlapalli K*, Wang D, Potnis KC, Richmond R, Krumholz H, Lee AI, Cuker A, Goshua G.
Blood
2025
January
FEATURED
RECOGNITIONS:

Gap: Proximal complement inhibition is cost-saving for patients with suboptimal response on C5 inhibitor therapy in the United States and can be cost-saving in international jurisdictions (Penn-Yale collaboration).

PRACTICAL IMPACT:

Decreasing alloimmunization-specific mortality in sickle cell disease in the United States: Cost-effectiveness of a shared transfusion resource

Ito S, Pandya A, Hauser RG, Krishnamurti L, Stites E, Tormey C, Krumholz HM, Hendrickson JE, Goshua G
American Journal of Hematology
2024
April
FEATURED
RECOGNITIONS:

Gap: Supporting the mission of the 501(c)(3) Alloantibody Exchange www.alloantibody.org. 2022 ASH Press Program Selection.

PRACTICAL IMPACT:
Abstract Futuristic Background

Publications

bottom of page